Stereotactic body radiation therapy significantly improved quality of life outcomes, including urinary incontinence and ...

Men with prostate cancer face different long-term risks depending on whether they choose surgery or radiation therapy, with ...

Learn about common side effects of radioligand therapy for metastatic prostate cancer and effective strategies to manage them for better outcomes.

Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a precision guided, biotech/life sciences company focused on advancing novel and potentially disruptive therapeutic assets, today ...

A new study from The Wistar Institute has found a link between the nervous system and the rapid development of neuroendocrine ...

September is Prostate Cancer Awareness Month, a time dedicated to early detection and support for men who face a life-changing diagnosis.   James Hugman is an East Texas ...

Prostate cancer is the most common cancer among U.S. men, and rates vary among different groups. When to get screened depends ...

The developer that has proposed construction of a large data center in Monticello will host a community open house this ...

SPARROW is an open-label, non-randomized, multicenter Phase 2/3 study that includes an initial Phase 2 dose optimization period followed by a Phase 3 diagnostic performance period. The Phase 3 ...

BUFFALO, N.Y. (WIVB) — Conversations about prostate cancer can be crucial. Not only can conversations about the disease help build a connection between those who are battling it, but these discussions ...

September is Prostate Cancer Awareness Month, a time doctors and advocates are urging men to get screened for a disease that ...

Key TakeawaysA national study of more than 20,000 men with prostate cancer compared long-term outcomes after radiation therapy or surgical removal of ...